Octavio Marquez - Mar 11, 2022 Form 3 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Role: President and CEO
Signature: Jonathan B. Leiken, Attorney-in-fact for Octavio Marquez
Stock symbol: DBD
Transactions as of: Mar 11, 2022
Transactions value $: $0
Form type: 3
Date filed: 3/16/2022, 04:38 PM
Next filing: May 12, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	DBD	Common Shares						277K	Mar 11, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	DBD	Non-Qualified Stock Option							Mar 11, 2022	Common Shares	15.9K	$34.13	Direct	F2
holding	DBD	Non-Qualified Stock Option							Mar 11, 2022	Common Shares	22.7K	$32.33	Direct	F2
holding	DBD	Non-Qualified Stock Option							Mar 11, 2022	Common Shares	16.4K	$27.39	Direct	F2
holding	DBD	Non-Qualified Stock Option							Mar 11, 2022	Common Shares	38K	$26.60	Direct	F3
holding	DBD	Non-Qualified Stock Option							Mar 11, 2022	Common Shares	19.8K	$18.75	Direct	F3
holding	DBD	Non-Qualified Stock Option							Mar 11, 2022	Common Shares	33.8K	$4.08	Direct	F3
holding	DBD	Non-Qualified Stock Option							Mar 11, 2022	Common Shares	9.33K	$11.96	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Number includes restricted stock units.
F2	Granted under the 1991 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.
F3	Granted under the 2017 Equity and Performance Incentive Plan; option is generally exercisable in annual increments of 1/3, 1/3, 1/3 beginning one year from the date of grant.